Metformin Abrogates Age-Associated Ovarian Fibrosis
The ovarian cancer risk factors of age and ovulation are curious because ovarian cancer incidence increases in postmenopausal women, long after ovulations have ceased. To determine how age and ovulation underlie ovarian cancer risk, we assessed the effects of these risk factors on the ovarian microe...
Uloženo v:
| Vydáno v: | Clinical cancer research Ročník 26; číslo 3; s. 632 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.02.2020
|
| ISSN: | 1078-0432, 1557-3265, 1557-3265 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | The ovarian cancer risk factors of age and ovulation are curious because ovarian cancer incidence increases in postmenopausal women, long after ovulations have ceased. To determine how age and ovulation underlie ovarian cancer risk, we assessed the effects of these risk factors on the ovarian microenvironment.
Aged C57/lcrfa mice (0-33 months old) were generated to assess the aged ovarian microenvironment. To expand our findings into human aging, we assembled a cohort of normal human ovaries (
= 18, 21-71 years old). To validate our findings, an independent cohort of normal human ovaries was assembled (
= 9, 41-82 years old).
We first validated the presence of age-associated murine ovarian fibrosis. Using interdisciplinary methodologies, we provide novel evidence that ovarian fibrosis also develops in human postmenopausal ovaries across two independent cohorts (
= 27). Fibrotic ovaries have an increased CD206
:CD68
cell ratio, CD8
T-cell infiltration, and profibrotic DPP4
αSMA
fibroblasts. Metformin use was associated with attenuated CD8
T-cell infiltration and reduced CD206
:CD68
cell ratio.
These data support a novel hypothesis that unifies the primary nonhereditary ovarian cancer risk factors through the development of ovarian fibrosis and the formation of a premetastatic niche, and suggests a potential use for metformin in ovarian cancer prophylaxis.
. |
|---|---|
| Bibliografie: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Commentary-3 content type line 23 |
| ISSN: | 1078-0432 1557-3265 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-19-0603 |